CADL (Candel) Wutah pendapatan triwulanan

Logo perusahaan publik Candel (CADL)

Candel Therapeutics (CADL) operates in the high-risk oncolytic virus segment, facing intense pressure from pharmaceutical behemoths. A lack of profitability and high laboratory costs leave the company dependent on clinical trial outcomes. However, the brand is valued for its safe methods of targeted tumor destruction. The quarterly revenue growth trajectory clearly demonstrates income dynamics, where the value is recorded at 0.00.

CADL (Candel Therapeutics) riwayat Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan candeltx.com (CADL)

Ringkesan analitik perusahaan:Candel (CADL)
Barang unggulan Candel Therapeutics

The indicator is based on a dynamic comparison of current operating revenues against the figures from the preceding quarter. This metric captures the rate of change in cash flow, allowing for the detection of business stagnation prior to the publication of financial reports. For Candel Therapeutics (CADL), this is critically important when scaling its network of oncology centers to meet the demand for immunotherapy. Analyzing quarterly revenue growth rates helps identify a slowdown in expansion in a timely manner and avoid capital losses.

Perusahaan pesaing

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|ARAY: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Citius Oncology Inc. (CTOR)|Wutah pendapatan kuartal marang kuartal TuHURA (HURA)|TARA - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Tingkat wutah pendapatan sajrone kuartal|TScan - Wutah pendapatan triwulanan|Champions Oncology, Inc. (CSBR) - Wutah dodolan triwulanan|XBIT (XBiotech Inc.) - Wutah dodolan triwulanan|CEL-SCI Corporation (CVM) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal OS Therapies|RADX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal artivabio.com (ARTV)|Tingkat wutah dodolan sajrone kuartal Adlai Nortye|Wutah pendapatan triwulanan VERU (Veru Corporation)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)